MAP Pharmaceuticals (MAPP) focuses on the development and commercialization of drugs in the field of neurology using its inhalation technologies. This stock is trading up 6.2% at $15.40 in recent trading.
Today's Volume: 505,000Average Volume: 192,397 Volume % Change: 409% From a technical perspective, MAPP is rebounding sharply higher today following the stock's recent selloff from $17.50 to a low of around $14.50. Shares of MAPP are just starting to move back above its 50-day moving average today of $15.35 with monster volume. Traders should continue to look for long biased trades as long as MAPP is trending above its 50-day with strong upside volume flows.